國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Hematologic cancersfrom molecular pa...

Sotomayor, Eduardo.

Hematologic cancersfrom molecular pathobiology to targeted therapeutics /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Hematologic cancersedited by Jianguo Tao, Eduardo Sotomayor.
其他題名:	from molecular pathobiology to targeted therapeutics /
其他作者:	Tao, Jianguo.
出版者:	Dordrecht :Springer Netherlands :2012.
面頁冊數:	vi, 426 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Leukemia.
電子資源:	http://dx.doi.org/10.1007/978-94-007-5028-9
ISBN:	9789400750289 (electronic bk.)

Hematologic cancersfrom molecular pathobiology to targeted therapeutics /
Hematologic cancersfrom molecular pathobiology to targeted therapeutics /[electronic resource] :edited by Jianguo Tao, Eduardo Sotomayor. - Dordrecht :Springer Netherlands :2012. - vi, 426 p. :ill., digital ;24 cm. - Cancer growth and progression ;v.14. - Cancer growth and progression ;v.14..

In the last decade, there has been a remarkable explosion of knowledge in hematologic cancer from basic molecular biology and pathology to clinical therapy. This has led to many new advance and insights in the understanding of pathobiology of malignant hematology. New knowledge of disease molecular pathology, cytogenetic, epigenetic and genomic alterations have provided new strategies to attack and eradicate tumor cells at molecular level and significantly impacted our current therapeutics for hematological malignancies. The recent and ongoing rapid expansion of knowledge in this area has become extensive, dynamic and diffuse over the literature and research publications. This has led to the need to capture and compile the new and current information about hematologic cancer with special emphasis on translation from molecular pathobiology to targeted therapeutics. In this book experts from around the world share their thoughts and knowledge about the pathobiology of hematologic cancer, as well as their view on current treatment approaches and future development in these malignant hematologic diseases. This book is well suited for hematology residents, fellows and hematology-oncology physicians, hematopathologist as well as basic research scientist in the area of hematologic malignancies.

ISBN: 9789400750289 (electronic bk.)Subjects--Topical Terms:

234134
Leukemia.

LC Class. No.: RC280.H47 / H46 2012

Dewey Class. No.: 616.99418

Hematologic cancersfrom molecular pathobiology to targeted therapeutics /
LDR:02214nmm a2200277 a 4500 001 354576
003 DE-He213
005 20121224134122.0
006 m d
007 cr nn 008maaau
008 130107s2012 ne s 0 eng d
020 $a 9789400750289 (electronic bk.)
020 $a 9789400750272 (paper)
035 $a 978-94-007-5028-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.H47 $b H46 2012
082 0 4 $a 616.99418 $2 23
090 $a RC280.H47 $b H487 2012
245 0 0 $a Hematologic cancers $h [electronic resource] : $b from molecular pathobiology to targeted therapeutics / $c edited by Jianguo Tao, Eduardo Sotomayor.
260 $a Dordrecht : $b Springer Netherlands : $b Imprint: Springer, $c 2012.
300 $a vi, 426 p. : $b ill., digital ; $c 24 cm.
490 1 $a Cancer growth and progression ; $v v.14
520 $a In the last decade, there has been a remarkable explosion of knowledge in hematologic cancer from basic molecular biology and pathology to clinical therapy. This has led to many new advance and insights in the understanding of pathobiology of malignant hematology. New knowledge of disease molecular pathology, cytogenetic, epigenetic and genomic alterations have provided new strategies to attack and eradicate tumor cells at molecular level and significantly impacted our current therapeutics for hematological malignancies. The recent and ongoing rapid expansion of knowledge in this area has become extensive, dynamic and diffuse over the literature and research publications. This has led to the need to capture and compile the new and current information about hematologic cancer with special emphasis on translation from molecular pathobiology to targeted therapeutics. In this book experts from around the world share their thoughts and knowledge about the pathobiology of hematologic cancer, as well as their view on current treatment approaches and future development in these malignant hematologic diseases. This book is well suited for hematology residents, fellows and hematology-oncology physicians, hematopathologist as well as basic research scientist in the area of hematologic malignancies.
650 0 $a Leukemia. $3 234134
650 0 $a Hematological oncology. $3 274898
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Cancer Research. $3 273660
650 2 4 $a Hematology. $3 274899
650 2 4 $a Laboratory Medicine. $3 276727
650 2 4 $a Molecular Medicine. $3 273932
650 2 4 $a Apoptosis. $3 193935
650 2 4 $a Cell Biology. $3 274165
700 1 $a Tao, Jianguo. $3 586808
700 1 $a Sotomayor, Eduardo. $3 586809
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Cancer growth and progression ; $v v.14. $3 586810
856 4 0 $u http://dx.doi.org/10.1007/978-94-007-5028-9
950 $a Medicine (Springer-11650)